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CD36 is a versatile receptor known to play a central
role in the development of atherosclerosis, the path-
ogenesis of malaria, and the removal of apoptotic
cells. Remarkably, the short cytosolically exposed
regions of CD36 lack identifiable motifs, which has
hampered elucidation of its mode of signaling. Using
a combination of phosphoprotein isolation, mass
spectrometry, superresolution imaging, and gene
silencing, we have determined that the receptor
induces ligand internalization through a heteromeric
complex consisting of CD36, b1 and/or b2 integrins,
and the tetraspanins CD9 and/or CD81. This receptor
complex serves to link CD36 to the adaptor FcRg,
which bears an immunoreceptor tyrosine activation
motif. By coupling to FcRg, CD36 is able to engage
Src-family kinases and Syk, which in turn drives the
internalization of CD36 and its bound ligands.
INTRODUCTION
CD36, a highly glycosylated transmembrane protein belonging
to the class B scavenger receptor family, is expressed by several
cell types such as adipocytes, erythrocytes, platelets, and endo-
thelial and myeloid cells. It binds a broad range of endogenous
ligands, including proteins like amyloid-b (Coraci et al., 2002),
collagen (Tandon et al., 1989), and thrombospondin (Asch
et al., 1987), and lipids that include oxidized low-density lipopro-
tein (oxLDL; Endemann et al., 1993), intact and oxidized phos-
phatidylserine (Rigotti et al., 1995; Greenberg et al., 2006), and
long-chain fatty acids (Abumrad et al., 1993). In addition, CD36
also recognizes exogenous proteins like thePlasmodium falcipa-
rum protein PfEMP1 (Baruch et al., 1996) and lipids such as
bacterial diacylglycerides (Hoebe et al., 2005). By interacting
with such ligands, the scavenger receptor plays a critical role
in the removal of apoptotic bodies and of Plasmodium-infected
red blood cells (McGilvray et al., 2000; Patel et al., 2004), and
its association with thrombospondin is thought to have antimeta-
static effects (Clezardin et al., 1993; Uray et al., 2004). However,372 Developmental Cell 24, 372–383, February 25, 2013 ª2013 Elsevnot all of these interactions are beneficial: CD36 contributes to
the retention of macrophages at atherosclerotic lesions and their
subsequent conversion into foam cells (Febbraio et al., 2000),
contributes to macrophage apoptosis and to the sterile inflam-
mation induced by oxLDL by interacting with toll-like receptors
(TLRs) 2, 4, and/or 6 (Manning-Tobin et al., 2009; Seimon
et al., 2010; Stewart et al., 2010), and is also implicated in the
progression of Alzheimer dementia through its proinflammatory
engagement of amyloid-b (El Khoury et al., 2003; Coraci et al.,
2002).
The ligands recognized by CD36 are generally multivalent and
can therefore engage multiple receptors simultaneously. The re-
sulting formation of CD36 clusters initiates signal transduction
and internalization of receptor-ligand complexes. Remarkably,
despite the broad biological importance of CD36, the signaling
pathways that direct its internalization remain to be identified.
Elucidation of the mode of action of the receptor has been
stymied by the absence of discernible signalingmotifs in its short
intracellular domains (Armesilla and Vega, 1994). Together with
the varied chemical nature of its ligands and the heterogeneous
cellular responses they elicit, this suggests that CD36 signals in
conjunction with coreceptors or accessory molecules. Indeed,
several proteins have been implicated as CD36 coreceptors,
including TLR2, TLR4, and TLR6, as well as the a3b1 and avb5
integrins (Stewart et al., 2010; Calzada et al., 2004; Chang and
Finnemann, 2007). The dependency on coreceptor signaling is
strongly ligand specific. For example, signaling via TLR4/6 and
their downstream adaptors MyD88 and TRIF is required for
proinflammatory cytokine production after engagement of
oxLDL and fibrillar amyloid-b (Stewart et al., 2010). In contrast,
neither TLR receptors nor their downstream signaling compo-
nents are required for the production of proinflammatory cyto-
kines following the CD36-dependent uptake of malaria-infected
erythrocytes (Erdman et al., 2009). Of note, none of the signaling
pathways identified to date dictate the internalization of CD36,
and instead seem to regulate downstream events such as
gene transcription.
There is currently disagreement whether CD36 is internalized
via caveolae (Uittenbogaard et al., 2000; Ring et al., 2006;
Truong et al., 2006), macropinocytosis (Boyanovsky et al.,
2009), clathrin-mediated endocytosis (Shamsul et al., 2010), or
an actin-dependent process distinct from macropinocytosisier Inc.
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Figure 1. Activation of CD36 and Immunoprecipitation of Tyrosine-
Phosphorylated Proteins
(A) Internalization of CD36 and uptake of oxLDL bymurinemacrophages.Wild-
type (WT) or CD36/ (KO) mouse peritoneal macrophages were incubated
either with anti-CD36 IgA that was then crosslinked using Cy3-tagged F(ab0)2
(top panels) or with DiI-labeled oxLDL. After incubation at 37C for 15 min,
noninternalized ligand was removed by acid washing and the cells were
imaged.
(B) Silver-stained SDS-PAGE gel of phosphotyrosine immunoprecipitates from
unstimulated (Basal) and CD36 crosslinked (CD36 X-link) cells. The gel shown
is representative of four similar experiments.
(C) Phosphotyrosine (pY) immunoprecipitates were prepared from un-
stimulated (Basal) or CD36 crosslinked cells (CD36 X-link). The precipitates
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Developm(Collins et al., 2009). Recent evidence suggests that CD36
uptake requires Src-family kinases, Jnk, and Rho-family
GTPases, but the pathway(s) leading to their activation remains
unclear. We used a combination of immunoprecipitation, mass
spectrometry (MS), and gene silencing or deletion to demon-
strate that CD36 exists in heterogeneous membrane complexes
containing b1 and/or b2 integrins, and the tetraspanins CD9 and
CD81, and that these ancillary molecules bridge CD36 to the im-
munoreceptor tyrosine activation motif (ITAM)-bearing adaptor
FcRg (FcER1G), which is required for the CD36-dependent acti-
vation of Syk. By coupling it to an ITAM adaptor, this complex
allows CD36 to engage Src and Syk kinases, thus triggering
the internalization of CD36 and its bound ligands.
RESULTS
Identification of Proteins Phosphorylated in Response
to CD36 Crosslinking
The comparatively large particles that are the physiological
targets of phagocytic receptors expose a multiplicity of ligands
that can engage a variety of different receptors. To selectively
stimulate CD36 in RAW264.7 cells (called RAW hereafter) while
avoiding spurious stimulation of Fcg receptors, which are abun-
dant on the surface of macrophages, we employed a primary
anti-CD36 immunoglobulin A (IgA), followed by a secondary
F(ab0)2. The specificity of these antibodies was initially demon-
strated comparing macrophages isolated from wild-type (WT)
and CD36-deficient mice. As shown in Figure 1A, when anti-
CD36 IgAwas allowed to bind and crosslinked usingCy3-tagged
F(ab0)2, the complexes were formed and internalized by WT but
no labeling or internalization was detectable in knockout cells.
Moreover, neither nonimmune IgA nor IgG was able to bind or
induce internalization. Figure 1A also illustrates that CD36 is
the predominant pathway underlying the uptake of oxLDL in
murine macrophages.
To identify components of the signaling pathway activated by
CD36, we sought to detect proteins that become tyrosine phos-
phorylated in response to receptor stimulation. Immunoprecipi-
tation with phosphotyrosine antibodies covalently coupled to
beads, and a gentle elution protocol using phenylphosphate,
were used to minimize contamination with immunoglobulins or
nonspecifically bound proteins. When eluates prepared from
untreated and crosslinked cells were compared by silver stain-
ing, it was apparent that stimulation of CD36 induced phos-
phorylation of numerous proteins and increased the degree of
phosphorylation of other proteins that are visibly phosphorylated
in the resting state (Figure 1B). Bands corresponding to proteins
that displayed a reproducible increase in phosphorylation were
excised and subjected toMS. This analysis identified 36 proteins
that were consistently tyrosine-phosphorylated in response to
CD36 crosslinking (Table 1).
Significantly, 13 of these proteins (Table 1) have previously
been identified as components of ITAM-dependent signalingwere then subjected to SDS-PAGE and immunoblotted with antibodies to
PLCg2, SHIP1, Syk, HCLS1, or BiP, as indicated. Immunoprecipitates (IP) are
shown to the left and or samples of the total lysates to the right. Each blot is
representative of three or four independent experiments.
See also Figure S1.
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Table 1. Proteins Phosphorylated in Response to CD36
Crosslinking, as Identified by Mass Spectrometry
of Phosphotyrosine Immunoprecipitates Prepared
from CD36-Crosslinked Cells
Protein UniProt Spectra
Dst Q91ZU6 1
MYH7B A2AQP0 1
Girdin Q5SNZ0 1
MTMR5 Q6ZPE2 1
ARAP1 Q4LDD4 3
Palld Q9ET54 1
PLCg2 Q8CIH5 3
Ssfa2 Q922B9 1
SHIP1 Q9ES52 12
Tsc1 Q9EP53 1
PERQ1 Q99MR1 1
ASAP2 Q7SIG6 2
Cbl P22682 6
Fes P16879 3
BCAP Q9EQ32 3
Fyb O35601 2
Dmnl1 Q8K1M6 2
Jup Q02257 1
Ston1 Q8CDJ8 1
Pkp1 P97350 4
BiP P20029 13
kSyk P48025 2
IRAK2 Q8CFA1 1
Lrriq4 A6H6A4 1
3BP-2 Q06649 6
LCP2 Q60787 5
HCLS1 P49710 10
Dok1 P97465 2
ILR7A P16872 1
Manael Q6P1J0 1
PPIP1 P97814 3
Skin-7 A7XV04 1
ActB P60710 4
IL1R2 Q8K084 1
Prdx2 Q5M9N9 1
Ptpn11 Q05C78 2
‘‘Protein’’ is the protein symbol and ‘‘UniProt’’ is the proteins accession
number, as listed in the UniProt database (http://www.uniprot.org).
‘‘Spectra’’ refers to the number of unique peptides identified in the MS
screens. Data represent the aggregate results of four separate experi-
ments. Proteins in bold have been previously associated with ITAM-
dependent signaling pathways.
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adaptor or coreceptor. The identity of some of the proteins
detected by MS was verified by immunoblotting eluates of the
phosphotyrosine immunoprecipitate. Four candidates were
selected based on their previously identified roles in either
ITAM-dependent signaling or phagocytosis and on the avail-374 Developmental Cell 24, 372–383, February 25, 2013 ª2013 Elsevability of antibodies. As illustrated in Figure 1C, immunoblotting
confirmed the presence of PLCg2, SHIP1, Syk, and HCLS-1 in
the immunoprecipitates. This conclusion was verified indepen-
dently by immunoprecipitating either PLCg2 or SHIP1 and
blotting the precipitates for phosphotyrosine (Figure S1 available
online; the Syk and HCLS-1 antibodies tested were not suitable
for immunoprecipitation). By contrast, BiP was not immunopre-
cipitated under comparable conditions (Figure 1C), suggesting
that this abundant protein was a nonspecific contaminant
detected by the mass spectrometer in the phosphotyrosine
immunoprecipitates.
Src and Syk Are Required for CD36 Internalization
Of particular interest was the identification of Syk, a tyrosine
kinase known to be a central mediator of ITAM-dependent
signaling and phagocytosis. We therefore tested the role of
Syk and its upstream activator, the Src-family kinases, in
CD36-dependent signaling and CD36 internalization. As illus-
trated in Figure 2A, the marked phosphorylation induced by
CD36 crosslinking could be inhibited by addition of the Src-
family kinase inhibitor PP1. Phospho-specific antibodies re-
vealed that stimulation of CD36 promoted phosphorylation of
Syk on Y525/Y526 (Figure 2B); phosphorylation of these sites
is indicative of Syk activation (Kurosaki et al., 1994). The phos-
phorylation—and hence the activation—of Syk could be in-
hibited by PP1 (data not shown), implying that Src-family kinases
were required for the process, as is the case in other canonical
ITAM-dependent pathways (Johnson et al., 1995; Schmitz
et al., 1996; Zoller et al., 1997).
We proceeded to test whether the Src/Syk signaling pathway
is required for the internalization of ligated CD36. Pharmacolog-
ical inhibition of Src-family kinases (using PP1) or Syk (using
either piceatannol or compound SykIV) markedly depressed
internalization of crosslinked CD36 (Figures 2C and 2D), without
reducing the surface exposure of CD36. Endocytosis of CD36
induced by the (patho)physiological ligand oxLDL was also
markedly inhibited by Src-family or Syk inhibitors (Figure 2E).
To circumvent possible nonspecific effects of the inhibitors,
the role of Syk in receptor endocytosis was also tested in Syk
small interfering RNA (siRNA)-treated RAW macrophages (Fig-
ure 2F) and in bone-marrow-derived macrophages isolated
from Syk-deficient mice (Figure 2G; Crowley et al., 1997). As
with the pharmacological inhibitors, depletion or knockout of
Syk clearly reduced CD36 internalization without altering the
expression of CD36 at the cell surface. Together, these results
demonstrate that optimal CD36 internalization requires Src and
Syk, and that the Src-family kinases act upstream of Syk.
CD36 Associates with b1 and b2 Integrins
Although the previous experiments demonstrated that CD36
internalization requires Src and Syk, it is unclear how CD36
engages these signaling molecules. Canonically, Src phosphor-
ylates ITAM motifs, resulting in the recruitment of Syk via its
tandem SH2 domains. Src then phosphorylates Syk, inducing
downstream signaling. However, CD36 contains no motifs
known to interact with Syk, and CD36 is not known to interact
with any ITAM-bearing adaptors or coreceptors. We therefore
hypothesized that CD36 induces Syk signaling through a hereto-
fore-unknown ancillary molecule, which we attempted to identifyier Inc.
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Figure 2. Src-Family and Syk Kinases Are Required for CD36 Internalization
(A) Phosphotyrosine immunoblot of identical amounts of cell lysates from vehicle control or PP1-treated (PP1) cells that were treated with anti-CD36 IgA alone
(Primary Ab) or subjected to CD36 crosslinking (CD36 x-link) by subsequent incubation at 37C with F(ab0 )2. Blot is representative of four similar experiments.
GAPDH was immunoblotted (below) to ensure equal loading.
(B) Immunoblot of active (phosphorylated) Syk of cell lysates from vehicle control or PP1-treated (PP1) cells that were either otherwise untreated (Basal) or
subjected to CD36 crosslinking (CD36 X-Link).
(C) Assessment of internalization of crosslinked CD36 in vehicle control, PP1-treated (PP1), or piceatannol-treated (Pice) cells. Fluorescent cholera toxin subunit
B (CTx) was used to demarcate the plasma membrane. Confocal images are representative of multiple fields from five independent experiments.
(D) Quantification of the level of surface CD36 prior to crosslinking (black bars) and of its internalization in response to crosslinking (gray bars) in RAW cells treated
with vehicle control only, PP1 (PP1), piceatannol (Pice), or Syk inhibitor IV (Syk IV).
(E) Quantification of the internalization of oxLDL by RAW cells treated with vehicle control only (UT), PP1 (PP1), Syk inhibitor IV (Syk IV), or piceatannol (Pice). Data
were normalized to untreated control and are presented as means ± SE of at least 200 cells for each condition, from three separate experiments of each kind.
(F) Quantification of the level of surface CD36 prior to crosslinking (black bars) and of its internalization in response to crosslinking (gray bars) in cells treated with
scrambled (Scrm) or Syk-specific siRNA. The top lanes in the insert show a typical immunoblot validating the effectiveness of the siRNA-induced knockdown of
Syk, whereas the bottom lanes show that loading, assessed by GAPDH blotting, was comparable.
(G) Internalization of crosslinked CD36 in bone-marrow-derived macrophage from C57Bl/6 (WT) or Syk-deficient (Syk/) mice.
Data in (D)–(F) were normalized to untreated control and are presented asmeans ± SE of at least three separate experiments of each kind. The asterisks denote p <
0.05compared tountreated, scrambledsiRNA-treated,orWTcells, respectively, calculatedusingANOVAwithBonferroni correction (D)orStudent’s t test (EandF).
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Syk-Mediated Signaling of CD36 Internalizationby immunoprecipitation followed by MS. Anti-CD36 IgA was
used to precipitate the receptor from lysates of peritoneal
macrophages derived from WT C57BL/6 mice or, as a controlDevelopmfor specificity, from CD36 knockout (CD36/) mice. Immuno-
precipitated proteins were analyzed by SDS-PAGE and silver
staining and bands that were unique to the WT sample wereental Cell 24, 372–383, February 25, 2013 ª2013 Elsevier Inc. 375
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Figure 3. CD36 Is Associated with b1 and b2 Integrins
(A) Coprecipitation of b1 and b2 integrinswith CD36. CD36 immunoprecipitates were prepared frommacrophages obtained fromwild-type C57Bl/6 (WT) or CD36-
deficient (CD36/) mice. After SDS-PAGE, the immunoprecipitated material was blotted with antibodies to CD36 (top), the integrin b1 chain (middle), or the
integrin b2 chain (bottom). Samples of the total lysates are shown to the right, validating comparable loading and the absence of CD36 in CD36
/macrophages.
The immunoblots shown are representative of three experiments.
(B) Coprecipitation of CD36 with b2 integrins. b2 integrin immunoprecipitates were prepared from macrophages obtained from wild-type C57Bl/6 (WT) or CD36-
deficient (CD36/) mice. After SDS-PAGE, the immunoprecipitated material was blotted with antibodies to b2 integrins (top) or CD36 (bottom). Samples of the
total lysates are shown to the right, validating comparable loading. The immunoblots shown are representative of three experiments.
(C and D) Analysis of the spatial association of CD36 and b1 integrin (C) or CD36 and b2 integrin (D) in the plasma membrane of RAW macrophages (solid line)
compared to the predicted separation based on randomized particle positions (simulated particle positions; dotted line). The histograms shown are repre-
sentative of five experiments, each combining data from 20 fields.
(E) Comparison of the spatial association betweenCD36 and the b1/b2 integrinsmeasured experimentally (measured coincidence) with the predicted coincidence
based on randomized particle positions (simulated random positions). Data are means ± SE of measurements from 100 cells in five independent experiments.
Asterisk denotes p < 0.05 compared to measured coincidence, paired t test.
(F) Knockout of the b2 integrin Mac-1 reduces the proportion of CD36 undergoing confined diffusion. *p < 0.05 compared to C57BL/6 (Student’s t test, n = 3).
See also Figure S2.
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Syk-Mediated Signaling of CD36 Internalizationsubjected to MS. In addition to a prominent band correspond-
ing to CD36, both the alpha and beta subunits of the integrin
Mac-1 (amb2) were detected solely in the WT precipitate. The
association between the b2 subunit of Mac-1 and CD36 was
confirmed independently by immunoblotting, which demon-
strated the presence of the integrin in immunoprecipitates from376 Developmental Cell 24, 372–383, February 25, 2013 ª2013 ElsevWTbut not CD36 knockout cells (Figure 3A). The same approach
confirmed the previously reported association between CD36
and b1 integrin (Figure 3A; Miao et al., 2001). The association
between b2 and CD36 was validated independently by immuno-
precipitating the integrin subunit, followed by immunoblotting of
CD36 (Figure 3B).ier Inc.
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Syk-Mediated Signaling of CD36 InternalizationBecause incomplete solubilization or spurious association
following solubilization can lead to nonspecific coimmunopreci-
pitation of transmembrane proteins, we assessed the asso-
ciation of CD36 with the b1 and b2 integrins using a superreso-
lution microscopy approach (see Supplemental Experimental
Procedures and Figure S2 for details and validation). Cells
were fixed and dual labeled with distinct secondary antibodies
to detect the position of CD36 and the integrins. The relative
distances measured with subdiffraction resolution were com-
pared to a theoretical distribution generated while assuming
that the two types of molecules are distributed randomly on
the cell surface. Validation of this approach, termed spatial
apposition analysis (SAA) hereafter, is provided in Figure S3
and Supplemental Experimental Procedures. Quantification of
the fraction of CD36-integrin pairs separated by less than the
colocalization distance criterion (CDC; see Experimental
Procedures for definition) revealed a considerable (3-fold)
enrichment in closely apposed CD36 and b1, compared to
what would be predicted from random distribution (Figures
3C and 3E). Analysis of CD36 and b2 integrin revealed a simi-
larly significant association (Figures 3D and 3E). Moreover,
genetic deletion of the b2 integrin Mac-1 increased the fraction
of CD36 undergoing free diffusion (Figure 3F), confirming the
association between CD36 and b2 integrins. Together, these
findings indicate that CD36 and the b1 and b2 integrins are
associated in situ.
The ITAM-Bearing Adaptor FcRg Is Required for CD36
Internalization
Although the previous experiments confirmed the association
between CD36 and the b1 and b2 integrins, they did not reveal
the mechanism whereby CD36 engages the Src/Syk signaling
pathway. However, integrin activation is associated with stimu-
lation of Src-family kinases and, despite lacking an ITAM or
other Syk-interacting motifs, integrins are known to engage
Syk (Fujii et al., 1994; Yan et al., 1997). It is therefore likely
that CD36 and integrins utilize a similar pathway to activate
Syk. Integrin activation of Syk requires the ITAM-bearing
adaptors DAP12 and FcRg (Mo´csai et al., 2006), small
(12 kDa and 9 kDa, respectively) transmembrane proteins that
exist in the macrophage plasma membrane as disulfide-linked
homodimers (Ku¨ster et al., 1990; Tomasello et al., 1998). We
therefore tested whether these adaptors associate with and
are required for signaling by CD36 complexes. Although not
detected in our MS screens, we found FcRg to coimmuno-
precipitate with CD36 in peritoneal macrophages (Figure 4A).
The specificity of the interaction is suggested by the absence
of FcRg from immunoprecipitates obtained from CD36-defi-
cient macrophages (Figure 4A). We were unable to perform
equivalent experiments for DAP12 due to the lack of suitable
antibodies.
We next tested the possible role of the ITAM-bearing adaptors
in CD36-initiated signaling and function. As illustrated in Figures
4B and 4C, CD36 internalization was impaired in bone-marrow-
derived macrophages from DAP12/FcRg double-knockout
mice. The decrease was of similar magnitude to that observed
in Syk-deficient macrophages (Figure 2F), leading us to hypoth-
esize that DAP12 and/or FcRgwere required for CD36-mediated
Syk activation. The individual contribution of each one of theDevelopmadaptors was investigated using siRNA in RAW cells. Silencing
of FcRg expression was validated by immunoblotting, while
RT-PCR was used for DAP12 due to the unavailability of anti-
bodies (Figure 4D). The effect of adaptor silencing on the
phosphorylation (and hence activation) of Syk is documented
in Figure 4E. Whereas reducing the expression of DAP12
had only a modest effect on Syk phosphorylation, silencing
FcRg had a profound effect and a similar degree of inhibition
was observed when both DAP12 and FcRgwere simultaneously
silenced (Figure 4E). In accordance with our previous observa-
tions (Figure 2), the decreased activation of Syk associated
with downregulation of FcRg impaired the internalization of
crosslinked CD36 (Figures 4F and 4G). Jointly, these observa-
tions suggest that phosphorylation of FcRg by Src-family
kinases is required for optimal internalization of activated CD36.
CD36 and FcRg Associate with Tetraspanins
The tetraspanins CD9 and CD81 have previously been found to
associate with CD36, as well as with integrins (Huang et al.,
2011; Chang and Finnemann, 2007; Miao et al., 2001; Gutier-
rez-Lopez et al., 2003; Thorne et al., 2000). Because tetraspanins
are thought to establish and stabilize interactions between trans-
membrane proteins (Hemler, 2005), we hypothesized that CD9
and/or CD81 may mediate the interactions among CD36, integ-
rins, and FcRg, and lead to the formation of higher-order
complexes. Consistent with this hypothesis, FcRg and CD36
coprecipitate with CD9 (Figure 5A). Importantly, FcRg also
immunoprecipitated with CD9 in macrophages derived from
CD36-knockout mice (Figure 5A), suggesting that CD9 may act
as a scaffold between CD36 and FcRg.
Wide-field and ground-state depletion imaging (Figure 5B)
followed by SAA (Figures 5C, 5D, and S3) were used to es-
tablish that both CD9 and CD81 associate with CD36 and
with b1 and b2 integrins (Figure 5D) in the membranes of macro-
phages. Interestingly, CD81 displayed significant association
only with the b2-integrin (Figures 5D, S3D, and S3E), raising
the possibility that preferential association between CD36 and
specific tetraspanins may generate molecularly distinct sig-
naling platforms.
Tetraspanins Scaffold CD36-Integrin Complexes
The preceding experiments suggest the existence of tripartite
CD36-integrin-tetraspanin complexes. We analyzed if CD36
associates separately with integrins and tetraspanins, or
whether the interaction of integrins and tetraspanins with
CD36 is interdependent. To this end, we used siRNA to silence
CD9, CD81 and the integrin b1 and b2 chains separately and in
combination, followed by measurement of the association of
CD36 with the remaining components using SAA. As illustrated
in Figure 6A, expression of CD9 and CD81 on the surface of
RAW cells could be effectively silenced using siRNA. Downregu-
lation of CD9 resulted in a significant decrease in the association
between CD36 and both integrins (Figure 6B). Silencing CD81
expression similarly depressed association of CD36 with b2 in-
tegrins, but the decrease in b1 association was not significant.
Concomitant silencing of both tetraspanins had an additive
effect (Figure 6B).
The expression of integrins on the surface of RAW cells could
also be effectively depressed using siRNA (Figure 6C). A singleental Cell 24, 372–383, February 25, 2013 ª2013 Elsevier Inc. 377
A E
B
F
C
D
G
Figure 4. CD36 Internalization Requires the
ITAM-Bearing Adaptor FcRg
(A) Coprecipitation of FcRg with CD36. CD36
immunoprecipitates were prepared from macro-
phages obtained from wild-type C57Bl/6 (WT) or
CD36-deficient (CD36/) mice. After SDS-PAGE
the immunoprecipitated material was blotted with
antibodies to CD36 (top), FcRg chain (middle) or
actin (bottom), an abundant protein used to rule
out nonspecific precipitation (left) and to normalize
loading in total lysates (right). Blots are represen-
tative of three experiments.
(B and C) CD36 internalization was measured
in bone marrow macrophages from wild-type
C57Bl/6 (WT) and in DAP12/FcRg-deficient
(DAP12/FcRg/) mice. (B) Shown is a typical
confocal image, obtained after removal of
surface-exposed antibodies by an acid-wash.
(C) Summarized is the quantitation of 120 cells
from three independent experiments, obtained by
integration of the fluorescence of three-dimen-
sional projections of the entire cell. Asterisk
indicates p < 0.05 compared to wild-type using
Student’s t test.
(D) RAW macrophages were treated with scram-
bled (Scrm) siRNA, with siRNA targeting either
DAP12 or FcRg, or both. In the top lanes, the
effect of these treatments on the DAP12 mRNA
content is compared to that of GAPDH, measured
by RT-PCR. The numbers at the bottom indicate
the expression levels relative to the Scrm sample,
normalized to GAPDH content. In the bottom lane,
the FcRg protein level was assessed by immu-
noblotting. The numbers at the bottom indicate
the expression levels relative to the Scrm sample.
Data are representative of three experiments of
each type.
(E) RAW macrophages were treated with scram-
bled (Scrm) siRNA, siRNA targeting either DAP12
or FcRg, or both. The cells were then left
untreated (UT) or stimulated by CD36 cross-
linking. Identical amounts of cell lysates were then
subjected to SDS-PAGE followed by immuno-
blotting for phosphorylated (activated) Syk. The
blot is representative of four experiments.
(F and G) RAW macrophages were treated with
scrambled (Scrm) siRNA, siRNA targeting either
DAP12 or FcRg, or both. CD36 internalization was
then measured as in (B) and (C). Representative
images are illustrated in (F) and quantifications performed as above are summarized in (G). Data are means ± SE of 150 cells for each condition, from three
independent experiments. *p < 0.05 compared to Scrm; yp < 0.05 compared to DAP12 (calculated by ANOVA with Bonferroni correction).
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minimize off-target effects. Of note, decreasing the expression
of the integrins—whether separately or jointly—had little effect
on tetraspanin association with CD36 (Figure 6D); only a small
change in CD9 apposition to CD36 was noted when b2 was
silenced. Jointly, these findings indicate that while the integrins
are dispensable for tetraspanin binding to CD36, the tetraspa-
nins are required to establish tripartite complexes. These find-
ings support the notion that tetraspanins serve as molecular
scaffolds that stabilize signaling complexes at the membrane.
Moreover, our data imply that CD9 and CD81 form distinct
complexes, potentially creating different, ligand-specific sig-
naling platforms.378 Developmental Cell 24, 372–383, February 25, 2013 ª2013 ElsevIntegrins and Tetraspanins Are Required for CD36
Internalization
The physical association of CD36 with integrins and tetraspanins
noted in Figures 3, 5, and 6 is suggestive of a functional interac-
tion. We therefore tested whether the presence of CD9, CD81,
and/or of the b1 and b2 integrins is required for the function of
CD36, assessed by measuring endocytosis of oxLDL. As dis-
cussed above in the context of Figure 1, CD36 provides the
major route for oxLDL internalization. Treatment with CD9 or
CD81 siRNA resulted in a sizable, though incomplete, inhibition
of oxLDL uptake (Figure 7A). Two lines of evidence suggest
that this is caused by silencing of the intended tetraspanins
and not by off-target effects. First, the inhibition could beier Inc.
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Figure 5. CD36 and Integrins Form Higher-
Order Complexes with CD9 and CD81
(A) CD36 and FcRg coprecipitate with CD9. CD9
immunoprecipitates were prepared from macro-
phages obtained from wild-type C57Bl/6 (WT) or
CD36-deficient (CD36/) mice. After SDS-PAGE,
the immunoprecipitated material was blotted with
antibodies to CD36 (top), FcRg (bottom) or actin
(bottom), an abundant protein used to normalize
loading in total lysates (right). Shown are repre-
sentative blots of three experiments.
(B) Representative wide-field (left) and ground-
state depletion (right) image of CD9 (green) and
CD36 (red) in the plasma membrane of the same
RAW macrophage.
(C) Representative SAA trace of CD36 and CD9
in RAW macrophages (solid line) compared to
the predicted separation based on randomized
particle positions (Randomized; dotted line). Trace
is representative of three experiments, each
combining data from 25 fields.
(D) Comparison of the spatial association between
CD9 or CD81 with CD36, b1, and b2 measured
experimentally (black bars) with the predicted coincidence based on randomized particle positions (white bars). Data are mean ± SE of measurements
from 60 cells in three independent experiments. Asterisks denote p < 0.05 compared to measured coincidence.
See also Figure S3.
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orthologs, respectively. Indeed, overexpression of the tetraspa-
nins potentiated oxLDL uptake beyond the levels recorded in
control cells (Figure 7A). Second, very similar effects were ob-
tained when using any one of four individual siRNAs, but not
with irrelevant, scrambled siRNA (Figure S4). Silencing of b1 or
b2 was also accompanied by a very significant reduction in the
ability of the cells to internalize oxLDL (Figure 7B). The partial
inhibition obtained in each case most likely reflects the incom-
plete silencing of the integrins and/or functional redundancy of
the different integrin species. The specificity of the gene-
silencing strategy was tested using four distinct targeted
siRNAs, all of which depressed integrin expression, while irrele-
vant scrambled siRNA was without effect (Figure S4). A single
siRNA was used in the experiments of Figure 7B to minimize
off-target effects. Jointly, these results imply that both tetraspa-
nins and integrins are required for normal internalization of CD36
following engagement by ligands.
DISCUSSION
Our findings point to the existence of multimolecular complexes
of transmembrane proteins that include CD36, integrins, tetra-
spanins, and ITAM-bearing adaptors that enable the transmis-
sion of signals via Syk. These observations, together with earlier
findings that CD36 can associate with and activate Src-family
kinases (Huang et al., 1991), provide a defined pathway whereby
this receptor triggers internalization of important ligands like
modified LDL that can result in foam-cell and atheroma forma-
tion. Earlier studies determined that the internalization of CD36
occurs through a pathway distinct from macropinocytosis and
canonical endocytosis (Collins et al., 2009). This unconventional
internalization mechanism shares some similarities with the
Fcg receptor-mediated phagocytosis of IgG-opsonized parti-
cles, notably the requirement for Src-family kinases, Rho-familyDevelopmGTPases, and actin polymerization (Hackam et al., 1997; Cop-
polino et al., 2001; Hall et al., 2006). The current study has rein-
forced these similarities by identifying a role for Syk in the uptake
of CD36, akin to that played by this tyrosine kinase during phago-
cytosis (Kiefer et al., 1998). Phosphorylation of the scaffold
proteins Fyb and LCP2 (Coppolino et al., 2001) is also a common
consequence of the activation of CD36 and Fcg receptors. The
identification of these adaptor molecules is of particular interest
because they provide a possible link connecting Src/Syk activa-
tion, integrin signaling, actin reorganization, and Jnk signaling
(Mizuno et al., 2005; Wang et al., 2009; Barda-Saad et al.,
2010)—all processes known to be critical for the uptake of
CD36. Lipid-signaling enzymes known to regulate phagocytosis
were also identified in our screen, notably PLCg2—which is
known to be activated by Src-family kinases during phagocy-
tosis (Makranz et al., 2004; Palmbos et al., 2002)—and SHIP1,
a negative regulator of phosphatidylinositol 3,4,5-trisphosphate
signaling, which regulates Fcg receptor-mediated phagocytosis.
Of note, SHIP1 can be recruited to integrins by DOK1 (Horan
et al., 2007; Sattler et al., 2001), which was also identified in
our MS screen (Table 1).
CD36 is a receptor for a broad range of ligands, which can
be of proteinaceous (thrombospondin, fibronectin, collectin,
amyloid-b, PfEMP1) or lipidic (oxLDL, oxidized phospholipids,
bacterial diacylglycerides) nature. Remarkably, the cellular re-
sponses to these ligands vary, ranging from proinflammatory
to anti-inflammatory (Stewart et al., 2010; Chung et al., 2007;
Girkontaite et al., 2007). The recognition of such a broad
spectrum of ligands, and the diversity of the resultant cellular
responses, suggest the existence of multiple types of core-
ceptors that confer to the complexes distinct ligand-identifica-
tion and signaling properties. Indeed, previous studies have
identified several ligand-specific CD36 complexes: interaction
of TLR4 or TLR6 with CD36 is required for proinflammatory
signaling in response to amyloid-b or oxLDL (Stewart et al.,ental Cell 24, 372–383, February 25, 2013 ª2013 Elsevier Inc. 379
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Figure 6. Tetraspanins Scaffold CD36-Integrin Complexes
(A) Silencing of CD9 or CD81 gene expression using siRNA. RAW macro-
phages were treated with irrelevant, scrambled (scrm) siRNA or siRNA tar-
geting CD9 or CD81. After 48 hr, cells were immunostained to detect surface
CD9 or CD81. Representative immunofluorescence images are shown at
the top and the quantification of at least 200 cells from three independent
experiments is illustrated below. Fluorescence intensity is expressed relative
to the corresponding control (i.e., cells treated with scrambled siRNA and
stained with the appropriate antibody).
(B) Interactions of CD36 with b1 and b2 integrins as quantified using SAA
analysis in RAW macrophages 48 hr after treatment with scrambled (scrm)
siRNA, a pool of four oligonucleotides targeting CD9, or a single oligonucle-
otide targeting CD81.
(C) Silencing of the b1 or b2 integrin subunits using siRNA. Macrophages were
treated with irrelevant, scrambled (scrm) siRNA or siRNA targeting either b1 or
b2 integrin, as indicated. After 48 hr, cells were immunostained to detect
surface integrins. Representative immunofluorescence images are shown at
the top and the quantification of at least 200 cells from three independent
experiments is illustrated below. Fluorescence intensity is expressed relative
to the corresponding control (i.e., cells treated with scrambled siRNA and
stained with the appropriate antibody).
(D) Interactions of CD36 with CD9 or CD81 as quantified using SAA analysis in
RAW macrophages 48 hr after treatment with scrambled (scrm) siRNA or
a single siRNA targeting either b1 or b2. SRP, simulated random positions. Data
are means ± SE of three similar experiments. *p < 0.05 compared to measured
coincidence; yp < 0.05 compared to equivalent siRNA treatment in non-
randomized sample; ^p < 0.05 compared to CD9 or CD81 siRNA alone
(ANOVA with Bonferroni correction).
A B
Figure 7. Tetraspanins and Integrins Are Required for CD36
Function
(A) oxLDL uptake was quantified in RAW macrophages 48 hr after treatment
with scrambled (scrm) siRNA, a pool of four oligonucleotides targeting CD9, or
a single oligonucleotide targeting CD81. Where indicated (rescue), the cells
were cotransfected with green fluorescent protein and plasmids encoding the
human orthologs of CD9 or CD81, which were expressed on the surface of the
cells despite the presence of the siRNAs targeting the murine forms (not
illustrated).
(B) oxLDL uptake was quantified in RAW macrophages 48 hr after treatment
with irrelevant, scrambled (scrm) siRNA or with siRNA targeting either b1 or b2
integrin. Asterisk denotes p < 0.05 compared to scrm (ANOVA with Bonferroni
correction).
Data are means ± SE. See also Figure S4.
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CD36 is independent of TLRs and their downstream signaling
components (Baruch et al., 1996; Erdman et al., 2009). Integ-
rin-containing complexes have also been reported; recognition
of apoptotic retinal pigment epithelial cells appears to require
association of CD36 with CD81 and avb5 integrin (Chang and
Finnemann, 2007), and thrombospondin is bound by a3b1 integ-380 Developmental Cell 24, 372–383, February 25, 2013 ª2013 Elsevrin in conjunction with CD36 (Krutzsch et al., 1999; Li et al.,
1993).
The ability of CD36 to signal the uptake of oxLDL in macro-
phages is similarly dependent on its association with other
transmembrane proteins. Huang et al. (2011) reported that
CD9 not only associates with CD36 in murine macrophages,
but also is partially required for the internalization of oxLDL
and the formation of foam cells. Our findings extend these
observations, indicating that another tetraspanin, CD81, is also
associated with CD36 and required for its optimal function,
as are b1 and b2 integrins. Our data also suggest that the
tetraspanins mediate the association between CD36 and
the integrins, and that different tetraspanins may function in
the formation of distinct, possibly ligand-specific CD36 receptor
complexes.
It is unlikely that CD36 and all of these coreceptors exist
in a single, stable molecular entity. Instead, it seems more prob-
able that CD36 is part of several distinct signalosomes, which
need not be stable over time. Some of these may be cell-type
specific, but the evidence collected here and elsewhere sug-
gests that significant heterogeneity exists in the membrane of
individual macrophages and likely other cells as well. Further
evidence of heterogeneity comes from our studies of endocy-
tosis. Pharmacological inhibition or knockout/knockdown of
Src, Syk, or FcRg all had partial inhibitory effects on CD36 inter-
nalization, implying that in every instance studied at least one
additional internalization pathwaymust exist. One potential route
is the caveolae-dependent pathway used by TLRs (Shuto et al.,
2005). This would be consistent with studies demonstrating
that caveolin-1 is required for CD36-dependent signaling under
some conditions (Tsai et al., 2011; Ring et al., 2006).
Although the exact nature of the CD36 complexes remains to
be defined, the salient feature of our findings is the presence ofier Inc.
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envisage FcRg to be attached to the signaling complex via the
tetraspanins CD9 and CD81, which also link to integrins that
can serve as coreceptors. This assembly enables certain CD36
ligands to signal via Syk and its downstream effectors, which
in other systems can promote actin remodeling. Other CD36
complexes, such as those involving TLR receptors, may use
different means of signaling and internalization pathways. The
coexistence of heterogeneous signalosomes would in this
manner explain the multiplicity of entry routes and the ability
to trigger either inflammatory or anti-inflammatory responses,
depending on the nature of the ligand.
EXPERIMENTAL PROCEDURES
Cell Isolation and Culture
RAW macrophages were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) with 10% fetal bovine serum (FBS) at 37C under 5% CO2. Peritoneal
murinemacrophageswere isolated as described previously (Patel et al., 2004).
Bone-marrow-derived macrophages were grown in whole-marrow cultures.
Mice were euthanized, the femurs and tibias removed, and the bone marrow
removed by perfusion with PBS. The marrow was passed 15 times through
a 21G needle to produce a single-cell suspension, which was plated in
DMEM with 10% FBS, 100 ng/ml murine macrophage colony-stimulating
factor, and penicillin/streptomycin/gentamicin. Cultures were maintained for
5 days, and after removal of nonadherent cells, the adherent cells were
cultured in fresh medium for an additional 2–3 days to complete maturation.
siRNA Treatment
DAP12 and FcRg siRNA was transfected into RAW macrophages by electro-
poration using an Amaxa apparatus and a Nucleofect V kit, as per the manu-
facturer’s instructions. Cells were then plated at 50% confluence and
incubated for 24–32 hr. Knockdown was confirmed by immunoblotting or
RT-PCR. Knockdown experiments were performed using a Mirus kit and an
Amaxa electroporation apparatus. Knockdown was confirmed by immuno-
blotting. Human CD9, CD81, and b2 integrin plasmids were obtained from
Addgene. Human b1 integrin complementary DNA was from the Hospital for
Sick Children’s Signaling and Degradation Network (SIDNET) collection.
Rescue experiments were performed by coelectroporating the relevant mouse
siRNA and human rescue and GFP plasmids and incubating for 48 hr.
Oxidized LDL Uptake
Cells were treated with 1 mg/ml DiI-labeled oxLDL for 20 min. Noninternalized
oxLDL was stripped off the cell surface by brief treatment with trypsin.
Phosphotyrosine Immunoprecipitation and MS
RAW macrophages were grown to 80% confluence on 100 mm diameter
plates. Cells were serum-starved for 3 hr and cooled on ice. CD36 was cross-
linked by incubationwith anti-CD36 IgA (1:100) for 20min, followed by a 20min
incubation with a crosslinking secondary F(ab0)2 (1:100). The cells were
washed three times in cold PBS and then scraped into immunoprecipitation
buffer (20 mM Tris-HCl, 0.15 M NaCl, 2 mM EDTA, 1% NP40, 10% glycerol,
and phosphatase/protease inhibitors). The resulting suspensions were rotated
for 40 min at 4C, and centrifuged at 16,000 3 g for 15 min to remove nuclei
and large debris. Next, 40 ml anti-phosphotyrosine agarose slurry was added
to 1 ml cleared lysate and incubated under constant mixing for 12 hr at 4C.
Bound proteins were recovered by centrifugation at 16,000 3 g for 30 s at
4C. The agarose beads were washed five times with cold PBS and bound
proteins were next eluted by incubating the pellet in 70 ml PBS containing
25 mg/ml phenylphosphate for 20 min at 4C, mixing constantly. Eluted
proteins were separated on a 10% SDS-PAGE gel and visualized using silver
staining. Bands of interest were excised and the proteins identified via MS at
the Advanced Protein Technology Centre of the Hospital for Sick Children.
Silver stain was removed using a 15 min potassium ferricyanide (9.8 mg/ml)
and 100 mM sodium thiosulfate wash, the gel dehydrated in 50% acetoni-
trile/25 mM ammonium bicarbonate, reduced for 30 min with 37.5% b-mer-Developmcaptoethanol, alkylated using 100 mM iodoacetamide, and dehydrated a
second time. In-gel digestion was performed for 3 hr at 37C with 13 ng/l
trypsin. Peptides were recovered by extracting the gel three times with
25 mM ammonium bicarbonate and 5% formic acid. The peptides were sepa-
rated on an Agilent 1100 Capillary LC system equipped with a C18 precolumn
and a mLC analytical column that also served as a mESI emitter. Peptides were
identified with LTQ mass spectrometer in data-dependent mode, automati-
cally cycling through acquisition of a full-scan mass spectrum and three
MS/MS spectra recorded sequentially on the three most abundant ions
present in the initial MS scan. All MS/MS spectra searched against the NCBInr
database.
Immunoprecipitation of Membrane Proteins
Peritoneal macrophages were lysed for 2–3 hr at 4C in a buffer containing
1% Brij 99 (polyoxyethylene [20]-oleylether), 150 mM NaCl, 5 mM MgCl2,
and 25 mM HEPES (pH 7.5), supplemented with protease inhibitors (Miao
et al., 2001; Thorne et al., 2000). Insoluble material was removed by
centrifugation for 10 min at 13,000 3 g at 4C. Protein G or protein L
agarose beads (60 ml) were preincubated overnight with 10 mg of the
indicated antibodies. Antibody-coated beads were washed with Brij 99
lysis buffer and incubated with 2 ml cleared lysate overnight at 4C. The
beads were washed four times with lysis buffer, and the immunoprecipitated
proteins eluted in 50 ml 23-concentrated Laemmli buffer containing 100 mM
dithiothreitol by boiling for 5 min. Eluted samples were separated by
SDS-PAGE and transferred onto polyvinylidene fluoride membrane for
immunoblotting.
CD36 Internalization Assay
Macrophages were serum starved for 3 hr, transferred to medium RPMI-1640
without serum, and cooled to 10C to prevent endocytosis during labeling.
Anti-CD36 IgA (1:500) was added to the cells for 20min, the cells washed three
times in RPMI, and a crosslinking Cy3-tagged F(ab0)2 added to crosslink CD36.
Twentyminutes after the addition of the F(ab0 )2, the cells were washed 3-fold in
RPMI and warmed to 37C for 15min to allow for internalization of CD36. Inter-
nalization was then stopped by addition of RPMI at 10C, and surface-bound
antibodies that were not internalized were removed by a 1.5 min acid wash
(0.9% NaCl, 89 mM citric acid, 11 mM Na2HPO4 [pH 2.5], 10
C). Cells were
then fixed for 30 min in 4% paraformaldehyde at 10C. z stacks (0.5 mm/slice)
of the labeled cells were acquired using a Zeiss Axiovert 200/Quorum spin-
ning-disc confocal microscope equipped with a 633/1.4 NA and 1003/1.4
NA oil immersion objectives and a heated stage. The number of CD36-positive
endosomes and the fluorescence per endosome was then quantified using
customized Matlab scripts.
Detection of Single Molecules
Detection of single molecules was performed as described previously (Jaqa-
man et al., 2008, 2011). See Supplemental Experimental Procedures for details
of labeling and single-particle tracking and for description and validation
of SAA.
Statistics
All ANOVA and t test statistics were performed using GraphPad Prism soft-
ware. All other statistical and mathematical analyses were performed using
custom scripts written in Mathworks Matlab software. Data are presented as
mean ± SE unless otherwise noted.
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